DJ Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ shed 3.90% to $54.95 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.26% to 7,599.96 and the Dow Jones Industrial Average rising 0.09% to 51,078.88.
Bristol Myers Squibb Co. closed 12.62% short of its 52-week high of $62.89, which the company achieved on March 2nd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.81% to $223.51, Pfizer Inc. $(PFE)$ fell 2.10% to $25.63, and Abbott Laboratories $(ABT)$ rose 2.55% to $87.78.
Trading volume (19.1 M) eclipsed its 50-day average volume of 11.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 01, 2026 16:37 ET (20:37 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments